Expertise in
2
conditions

Ahmet Alacacioglu

Izmir, TR 
Expertise in
2
conditions
Izmir, TR 

Overview

Ahmet Alacacioglu practices practicing medicine in Izmir, Turkey.

Mr. Alacacioglu is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Breast Cancer, Muscle Atrophy, and Premature Ejaculation.

He is actively involved in clinical research, co-authoring 139 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Izmir, 35360, Turkey
Other Locations
Ataturk, 35730, Turkey
Menemen, Turkey
Celebi, Turkey
Cigli, Turkey
Dokuz Eylul, Turkey
Balcova, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: March 04, 2026
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 3
LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy With or Without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy With or Without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Selpercatinib, Carboplatin, Cisplatin, Pemetrexed, Pembrolizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

139 Total Publications

Pretreatment Staging FDG PET-Derived Radiomic Score Predicts Progression-Free Survival in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy.
Pretreatment Staging FDG PET-Derived Radiomic Score Predicts Progression-Free Survival in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy.
Journal: Diagnostics (Basel, Switzerland)
Published: June 02, 2026

Frequently Asked Questions about Ahmet Alacacioglu

Is Ahmet Alacacioglu a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ahmet Alacacioglu is classified as an Advanced expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ahmet Alacacioglu participate in research or clinical trials?

Yes. Ahmet Alacacioglu has published 139 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Ahmet Alacacioglu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Alacacioglu's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile